>>On the Market

Healthcare Professionals: Please visit the Aggrastat product website.

>>In Development

Medicure is currently developing a transdermal delivery formulation of its lead drug
AGGRASTAT (tirofiban HCl).
Read more..

>>Latest News

January 27, 2015
Medicure Announces Shares for Debt SettlementsRead more

January 9, 2015
Medicure Announces Issuance of Shares Under Previously Announced Shares for Debt Settlement Read more

December 18, 2014
Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue Read more

Sign up to receive email updates such as Press Release nofications and other company news.

>>Clinical Trials

Read more on clinicaltrials.gov

Read more on clinicaltrials.gov

>>A Heart for Life

Medicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human
therapeutics. Find out more.